These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31541762)

  • 1. Inhibition of the PD-1/PD-L1 signaling pathway enhances innate immune response of alveolar macrophages to mycobacterium tuberculosis in mice.
    Hu JF; Zhang W; Zuo W; Tan HQ; Bai W
    Pulm Pharmacol Ther; 2020 Feb; 60():101842. PubMed ID: 31541762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium tuberculosis Specific CD8
    Suarez GV; Melucci Ganzarain CDC; Vecchione MB; Trifone CA; Marín Franco JL; Genoula M; Moraña EJ; Balboa L; Quiroga MF
    Sci Rep; 2019 Jan; 9(1):187. PubMed ID: 30655556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of PD-L1 signaling hinders macrophage defense against Mycobacterium tuberculosis via upregulating STAT3/IL-6 pathway.
    Qu P; Li X; Liu W; Zhou F; Xu X; Tang J; Sun M; Li J; Li H; Han Y; Hu C; Lei Y; Pan Q; Zhan L
    Microbes Infect; 2024; 26(5-6):105352. PubMed ID: 38729294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1 modulating Mycobacterium tuberculosis-specific polarized effector memory T cells response in tuberculosis pleurisy.
    Li J; Jin C; Wu C; Huang J
    J Leukoc Biol; 2019 Sep; 106(3):733-747. PubMed ID: 30861206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed death-1
    Singh A; Mohan A; Dey AB; Mitra DK
    Clin Exp Immunol; 2017 Feb; 187(2):269-283. PubMed ID: 27665733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in PD-1/PD-L1, PD-L2 signaling pathway and its role in host anti-tuberculosis immunity].
    Yu XW; Zhang JA; Xie JP
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 May; 47(5):485-489. PubMed ID: 38706074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells.
    Dong L; Lv H; Li W; Song Z; Li L; Zhou S; Qiu L; Qian Z; Liu X; Feng L; Meng B; Fu K; Wang X; Pan-Hammarström Q; Wang P; Wang X; Zhang H
    Oncotarget; 2016 May; 7(22):33350-62. PubMed ID: 27147575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis.
    Alvarez IB; Pasquinelli V; Jurado JO; Abbate E; Musella RM; de la Barrera SS; García VE
    J Infect Dis; 2010 Aug; 202(4):524-32. PubMed ID: 20617899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
    Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
    Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles  produced by bone marrow mesenchymal stem cells overexpressing programmed death-ligand 1 ameliorate dextran sodium sulfate-induced ulcerative colitis in rats by regulating Th17/Treg cell balance through PTEN/PI3K/AKT/mTOR axis.
    He H; Chen Q; Fan H; Leng XY; Zhu F; Gao F; Zhou Q; Dong Y; Yang J
    J Gastroenterol Hepatol; 2022 Dec; 37(12):2243-2254. PubMed ID: 36044618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.
    Jurado JO; Alvarez IB; Pasquinelli V; Martínez GJ; Quiroga MF; Abbate E; Musella RM; Chuluyan HE; García VE
    J Immunol; 2008 Jul; 181(1):116-25. PubMed ID: 18566376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
    Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in
    Liu Q; Ou Q; Shen L; Qiu C; Zhang B; Zhang W; Shao L; Gao Y; Chen ZW
    Front Immunol; 2019; 10():2430. PubMed ID: 31681314
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
    Dong Z; Liao B; Shen W; Sui C; Yang J
    Dig Dis Sci; 2020 Feb; 65(2):480-488. PubMed ID: 31410753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 Expression in Monocytes Correlates with Bacterial Burden and Treatment Outcomes in Active Pulmonary Tuberculosis.
    Pan SW; Shu CC; Huang JR; Lee CC; Tseng YH; Hung JJ; Hsu PK; Chen NJ; Su WJ; Feng JY; Chen YM
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli K12 Upregulates Programmed Cell Death Ligand 1 (PD-L1) Expression in Gamma Interferon-Sensitized Intestinal Epithelial Cells via the NF-κB Pathway.
    Lee SA; Wang Y; Liu F; Riordan SM; Liu L; Zhang L
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33046511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1/PD-L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K/Akt/mTOR signalling pathway.
    Zhao R; Song Y; Wang Y; Huang Y; Li Z; Cui Y; Yi M; Xia L; Zhuang W; Wu X; Zhou Y
    Cell Prolif; 2019 May; 52(3):e12571. PubMed ID: 30714229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed cell death-1/programmed cell death-ligand 1 inhibitors exert antiapoptosis and antiinflammatory activity in lipopolysaccharide stimulated murine alveolar macrophages.
    Jia L; Liu K; Fei T; Liu Q; Zhao X; Hou L; Zhang W
    Exp Ther Med; 2021 Apr; 21(4):400. PubMed ID: 33680122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1/PD-L pathway inhibits M.tb-specific CD4
    Shen L; Gao Y; Liu Y; Zhang B; Liu Q; Wu J; Fan L; Ou Q; Zhang W; Shao L
    Sci Rep; 2016 Dec; 6():38362. PubMed ID: 27924827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphoproteomics Identifies the Foamy Alveolar Macrophage as an M2 Phenotype with PD-L1 Expression in the Early Lesion of Post-Primary Tuberculosis: Implications for Host Immune Surveillance and Therapy.
    Hwang SA; Ali Y; Fedotova E; Hunter RL; Brown RE
    Ann Clin Lab Sci; 2020 Jul; 50(4):429-438. PubMed ID: 32826237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.